Interestingly, we identified that lymph node metastasis only and CDH1 wild type were associated with higher ORR and longer PFS in gastric SRCC treated with PD-1 antibody. The gene discussed is CDH1; the disease is metastatic malignant neoplasm in the lymph nodes.